Patent Assignment
Reel/Frame 063268/0124
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 061091 Frame 0390. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2023-04-07
Pages: 5
Assignors
YAO, YIHONG
Executed: 2022-04-08
LI, YANFENG
Executed: 2022-04-08
WEI, YUTIAN
Executed: 2022-04-08
ZHU, SHIGUI
Executed: 2022-04-08
YAO, XIN
Executed: 2022-04-08
HUANG, JIAQI
Executed: 2022-04-08
Assignee
CELLULAR BIOMEDICINE GROUP HK LTD.
ROOM 417, 4TH FLOOR, LIPPO CENTRE, TOWER TWO, NO.89 QUEENSWAY, ADMIRALTY, HONG KONG, CHINA
Covered Property
(1)
Combined Chimeric Antigen Receptor Targeting CD19 and CD20 and Application Thereof
Application:
17/911,502 →
Publication:
US 2023/0104705
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 14, 2022
From: YAO, YIHONG; LI, YANFENG; WEI, YUTIAN; ZHU, SHIGUI
To: CELLULAR BIOPHARMACEUTICAL GROUP HK LTD.
Reel/Frame 061091/0390 →
Assignment of Assignor's Interest
Dec 15, 2022
From: CELLULAR BIOMEDICINE GROUP HK LTD.
To: CELLULAR BIOMEDICINE GROUP INC.
Reel/Frame 062100/0469 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →